Abstract
ObjectiveThis study is to document the clinical characteristics and improvement in management of acute myocardial infarction (AMI) in Chinese population.ResultsThis study included 64,654 patients (23,805 patients in 2011, 40,849 patients in 2013), of which STEMI and NSTEMI account for 85.09% and 14.91%, respectively. From 2011 to 2013, significant improvement has been achieved in the recanalization rate of PCI (96.01% vs. 98.63%, P < 0.001) and in-hospital deaths (4.52% vs. 3.55%, P = 0.038). Although the time of door-to-balloon and the duration of PCI were satisfactorily controlled within 90min and 60min, respectively, the onset-to-FMC time (≈3.5h) and door-to-thrombolysis time (≈1.1h) limited the efficiency of management. The total cost of medical care showed no increase from 2011 to 2013, but the patient's paid Portion decreased from 20.33% to 13.96%.Materials and MethodsThe AMI patients admitted in the general hospitals in 2011 and 2013 were retrospectively analyzed according to the data reported to the Single Disease Quality Control Information Systemissued by Chinese Hospital Association.ConclusionCompared to the Western countries, STEMI accounted for a larger portion of AMI, and the AMI management in China basically meets the standards of the quality control of guidelines. With improvement of management, there was no increase in the total medical cost, while the patient's paid portion was actually reduced. In future, improvement of transportation strategy and the public medical education are recommended to shorten the onset-to-FMC time to further improve the outcome of AMI patients.
Highlights
Contrast to the Western society, the incidence of acute myocardial infarction (AMI) increases dramatically in China with the change of lifestyle and prolonged life span
Compared to the Western countries, segment elevation myocardial infarction (STEMI) accounted for a larger portion of AMI, and the AMI management in China basically meets the standards of the quality control of guidelines
Improvement of transportation strategy and the public medical education are recommended to shorten the onset-to-FMC time to further improve the outcome of AMI patients
Summary
Contrast to the Western society, the incidence of acute myocardial infarction (AMI) increases dramatically in China with the change of lifestyle and prolonged life span. There are approximately 2.5 million AMI patients in China [1], and this figure is predicted to approach 23 million in 2030 [2]. No studies have characterized the current clinical characteristics and www.impactjournals.com/oncotarget. AMI, acute myocardial infarction; NSTEMI, non ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction. Medical management of AMI in Chinese population. The present study aims to assess the clinical profiles and the improvement in management of AMI in Chinese population in 2011 and 2013
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
